Abstract
Cell-cell communication during vascular development and tumour angiogenesis seems to involve at least five endothelial cell-specific tyrosine kinase receptors belonging to two distinct subclasses: two receptors of the Tie family, and three vascular endothelial cell growth factor receptors, VEGFR-1, -2 and -3, originally named Fltl (Fms-like tyrosine kinase), KDR/Flk-1 (Kinase insert-domain containing receptor or fetal-liver kinase-1) and Flt4, respectively. VEGFRs are subclass-III receptor tyrosine kinases, homologous to the platelet-derived growth factor (PDGF)-receptor family, having seven immunoglobulin homology domains in the extracellular domain, and a tyrosine kinase intracellular domain split by a kinase insert sequence (for recent reviews, see Klagsbrun and D’Amore 1996; Folkman and D’Amore 1996; Mustonen and Alitalo 1995; Korpelainen and Alitalo, 1998, Claesson-WELSH, this book).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor-D (VEGF-D) is a ligand for the tyrosine kinase VEGF receptor-2 (Flkl) and VEGF receptor-3 (Flt4). Proc Natl Acad Sci USA 95:548–553.
Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, McMahon J, Wasmuth J, Huebner K, Alitalo K (1992) FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 52:746–748.
Armstrong E, Kastury K, Aprelikova O, Bullrich F, Nezelof C, Gogusev J, Wasmuth JJ, Alitalo K, Morris S, Huebner K (1993) FLT4 receptor tyrosine kinase gene mapping to chromosome band 5q35 in relation to the t(2;5), t(5;6), and t(3;5) translocations. Genes Chromosom Cancer 7:144–151.
Beckstead JH, Wood GS, Fletcher V (1985) Evidence for the origin of Kaposi’s sarcoma from lymphatic endothelium. Am J Pathol 119:294–300.
Borg J-P, deLapeyrière O, Noguchi T, Rottapel R, Dubreuil P, Birnbaum D (1995) Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 10:973–984.
Dictor N, Andersson C (1988) Lymphaticovenous differentiation in Kaposi’s sarcoma. Am J Pathol 130:411–417.
Eichmann A, Corbel C, Jaffredo T, Bréant C, Joukov V, Kumar V, Alitalo K, le Douarin N (1998) Avian VEGF-C: cloning embryonic expression pattern and stimulation of the differentiation of VEGFR2 expressing endothelial cell precursors. Development (in press).
Eichmann A, Marcelle C, Breant C, Le Douarin NM (1996) Molecular cloning of Quek 1 and 2, two quail vascular endothelial growth factor (VEGF) receptor-like molecules. Gene 174:3–8.
Fielder W, Graeven U, Ergun S, Verago S, Kilic N, Stcokschlader M, Hossfeld DK (1997) Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 11:1234–1237.
Finnerty H, Kelleher K, Morris GE, Bean K, Merberg DM, Kriz R, Morris J C, Sookdeo H, Turner KJ, Wood CR (1993) Molecular cloning of murine FLT and FLT4. Oncogene 8:2293–2298.
Folkman J (1996) Angiogenesis and tumor growth. N Engl J Med 334:921.
Folkman J, D’Amore P (1996) Blood vessel formation: what is its molecular basis? Cell 87:1153–1155.
Fournier E, Dubreuil P, Birnbaum D, Borg JP (1995) Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 11:921–931.
Fournier E, Rosnet O, Marchetto S, Turck CW, Rottapel R, Pelicci PG, Birnbaum D, Borg JP (1996) Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of Shc is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase. J Biol Chem 271:12956–12963.
Galland F, Karamysheva A, Mattei M-G, Rosnet O, Marchetto S, Birnbaum D (1992) Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics. 13:475–478.
Galland F, Karamysheva A, Pebusque M-J, Borg J-P, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D (1993) The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8:1233–1240.
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425.
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298.
Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898–3911.
Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K (1998) A Recombinant Mutant Vascular Endothelial Growth Factor-C that Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities*
Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen M-T, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K (1998) Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res (in press).
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VM, Fang G-H, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development. Proc Natl Acad Sci USA 92:3566–3570.
Klagsbrun M, D’Amore P (1996) Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7:259–270.
Korpelainen, E. and Alitalo, K. 1998 Signaling angiogenesis and lymphangiogenesis. Curr. Opin. Cell Biol. 10:159–164.
Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829–3837.
Leak LV (1970) Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 2:361–391.
Leak LV (1971) Studies on the permeability of lymphatic capillaries. J Cell Biol 50:300–323.
Leak LV, Jamuar MP (1983) Ultrastructure of pulmonary lymphatic vessels. Am Rev Respir Dis 128:S59–S65.
Lee J, Gray A, Yuan J, Louth S-M, Avraham H, Wood W (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988–1992.
Liu Z-Y, Ganju RK, Wang J-F, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, Groopman JE (1997) Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi’s sarcoma cells. J Clin Invest 99:1798–1804.
Lymboussakis A, Partanen TA, Olofsson, B, Thomas-Crusells J, Fletcher CDM, de Waal RMW, Kaipainen A, Alitalo K (1998) Expression of the vascular endothelial growth factor C receptor VEGFR-3 in cutaneous lymphatic vascular endothelium and in vascular skin lesions Am J Pathol 153:395–403
Mustonen, T and Alitalo, K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129:895–898.
Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96–109.
Orlandini M, Marconcini L, Ferruzzi R, Oliviero S (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675–11680.
Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52:5738–5743.
Pajusola K, Aprelikova O, Armstrong E, Morris S, Alitalo K (1993) Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxyterminal tails are produced by alternative processing of primary transcripts. Oncogene 8:2931–2937.
Pajusola K, Aprelikova O, Pelicci G, Weich H, Claesson-Welsh L, Alitalo K (1994) Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9:3545–3555.
Rosnet O, Stephenson D, Mattei M-G, Marchetto S, Shibuya M, Chapman VM, Birnbaum D (1993) Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8:173–179.
Sabin FR (1902) On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1:367–391.
Salven P, Lymboussaki A, Heikkilä P, Jääskelä-Saari H, Aase K, von Euler G, Eriksson U, Joensuu H, Alitalo K (1998) Expression of the novel vascular endothelial growth factors VEGF-B and VEGF-C (submitted)
Wang JF, Ganju RK, Liu ZY, Avraham H, Avraham S, Groopman JE (1997) Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood 90:3507–3515.
Watkins-Chow DE, Douglas KR, Buckwalter MS, Probst FJ, Camper SA (1997) Construction of a 3-Mb contig and partial transcript map of mouse chromosome 11. Genomics 45:147–157.
Wilting J, Eichmann A, Christ B (1997) Expression of the avian VEGF receptor homologues quekl and quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tissue Res 288:207–223.
Yamada Y, Nezu J, Shimane M, Hirata Y (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42:483–188.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Taipale, J., Makinen, T., Arighi, E., Kukk, E., Karkkainen, M., Alitalo, K. (1999). Vascular Endothelial Growth Factor Receptor-3. In: Claesson-Welsh, L. (eds) Vascular Growth Factors and Angiogenesis. Current Topics in Microbiology and Immunology, vol 237. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59953-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-59953-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64195-4
Online ISBN: 978-3-642-59953-8
eBook Packages: Springer Book Archive